In recent years, significant advances have been made in the biotechnological and digital fields, which allow the generation and massive analysis of omics data related to health and disease. The development of technologies such as artificial intelligence, cloud computing, supercomputing, mobile and wearable devices, robotics, sensors, synthetic biology, bioengineering, 3D printing, nanotechnology, and photonics is causing a radical change in the tools available to design and produce new diagnostic systems and devices prognosis and therapy.
The project aims to deepen the study of gene expression at the individual cellular level, an essential aspect for the development of advanced diagnostic and prognostic systems, as well as for the identification of new therapeutics targets.
New personalized and targeted therapies will be developed, such as nanopharmaceuticals, which will be tested in preclinical models that reproduce human diseases.
Likewise, virtual reality models will be created for both the development of advanced surgical techniques and the training and training of health personnel in these techniques.
The great potential of this approach lies in the integration and adoption of these technologies, which will allow progress towards personalized or precision medicine that establishes, for each individual (or group of stratified individuals), tools for prevention, according to their predisposition to certain diseases, systems for early diagnosis, and methods to choose the therapeutic strategy that best suits each person in each circumstance.
Only with this integrative approach will we be able to respond to the most important health challenges we are currently facing: cancer, diseases associated with the aging process (such as neurodegenerative and chronic diseases), rare diseases and infectious diseases.
Grupo de Femtociencia y Microscopia de la Universidad de Castilla-La Mancha (Toledo).
IP – Abderrazzak Douhal.
Laboratorio de interacción con el usuario e ingeniería del software (LOUISE).
IP- Pascual González.
Grupo de Investigación Sistemas Inteligentes y Minería de Datos: SIMD en el Instituto de Investigación de informática I3A de Albacete.
Luis de la Ossa.
Urology Department
Hospital General Universitario de Albacete.
Dr. Antonio Santiago Salinas Sánchez.
The Neurodeath Associated Unit, the result of the collaboration between the University of Castilla-La Mancha (UCLM) and the Spanish National Research Council (CSIC), has recently strengthened its research capacity with the incorporation of a
The Neurodeath Associated Unit (Spanish National Research Council / University of Castilla-La Mancha), belonging to the Institute of Molecular Nanoscience (INAMOL) of the University of Castilla-La Mancha (UCLM), has published an article in the
Juan A. Sánchez Margallo, a researcher at the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) in Cáceres, recently participated in the 33rd. international congress of the European Association for Endoscopic Surgery (EAES), held in
